In the last trading session, 5.94 million Revelation Biosciences Inc (NASDAQ:REVB) shares changed hands as the company’s beta touched 0.12. With the company’s per share price at $0.50 changed hands at -$0.45 or -46.84% during last session, the market valuation stood at $2.17M. REVB’s last price was a discount, traded about -4952.0% off its 52-week high of $25.26. The share price had its 52-week low at $0.70, which suggests the last value was -40.0% down since then. When we look at Revelation Biosciences Inc’s average trading volume, we note the 10-day average is 1.38 million shares, with the 3-month average coming to 726.21K.
Analysts gave the Revelation Biosciences Inc (REVB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended REVB as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Instantly REVB was in red as seen at the end of in last trading. With action -32.00%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -96.64%, with the 5-day performance at -32.00% in the red. However, in the 30-day time frame, Revelation Biosciences Inc (NASDAQ:REVB) is -38.64% down. Looking at the short shares, we see there were 0.43 million shares sold at short interest cover period of 0.38 days.
Revelation Biosciences Inc (REVB) estimates and forecasts
Data shows that the Revelation Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -73.97% over the past 6 months, a 78.90% in annual growth rate that is considerably higher than the industry average of 17.60%.
The 2024 estimates are for Revelation Biosciences Inc earnings to decrease by -1371.70%.
REVB Dividends
Revelation Biosciences Inc is expected to release its next quarterly earnings report in January.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.12% of Revelation Biosciences Inc shares while 2.31% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.31%.
